Trial NCT01842594

View at ClinicalTrials.gov 
Org. Study IDs: 20120306M

Last trial update was posted on 2015-11-03

MeSH Interventions

Hydroxychloroquine Sirolimus

MeSH Conditions

Sarcoma

Other Conditions


Stopping Reasons

Most patients completed only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID